Clover Health Investments Corp(CLOV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.04 | Insider Own | 22.72% | Shs Outstand | 531.2M | Perf Week | -3.17% |
| Market Cap | 2.43B | Forward P/E | 45.66 | EPS next Y | 82.95% | Insider Trans | -1.5% | Shs Float | 410.5M | Perf Month | 6.26% |
| Enterprise Value | - | PEG | 0.69 | EPS next Q | -0.01 | Inst Own | 27.67% | Short Float | 6.32% | Perf Quarter | 9.83% |
| Income | -0.02B | P/S | 0.98 | EPS this Y | 51.71% | Inst Trans | 7.42% | Short Ratio | 6.21 | Perf Half Y | 66.55% |
| Sales | 2.48B | P/B | 6.01 | EPS next 5Y | 66.48% | ROA | -2.84% | Short Interest | 25.95M | Perf YTD | 94.89% |
| Book/sh | 0.76 | P/C | - | EPS past 3/5Y | 38.35% 35.85% | ROE | -5.1% | 52W High | -18.07% ($5.59) | Perf Year | 25.82% |
| Cash/sh | - | P/FCF | 32.78 | Sales past 3/5Y | -17.97% 22.9% | ROIC | -4.88% | 52W Low | 189.87% ($1.58) | Perf 3Y | 402.14% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 57.31% | Gross Margin | - | Volatility(W/M) | 3.8% 4.92% | Perf 5Y | -38.93% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | 54.04% | Oper. Margin | -0.74% | ATR (14) | 0.22 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | 346.63% | Profit Margin | -0.74% | RSI (14) | 49.05 | Recom | 1.8 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.5 | Sales Q/Q | 55.6% | SMA20 | -1.55% ($4.65) | Beta | 2.54 | Target Price | $5.5 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/11/4 | SMA50 | 1.8% ($4.5) | Rel Volume | 0.97 | Prev Close | $4.79 |
| Employees | 724 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 29.53% 2.05% | SMA200 | 29.63% ($3.53) | Avg Volume(3M) | 4.18M | Price | $4.58 |
| IPO | 2020/6/12 | Option/Short | Yes/Yes | Trades | 13564 | Volume | 4,070,913 | Change | -4.38% |
🍀 A US healthcare company that combines Medicare Advantage health insurance with medical data software. It provides Medicare Advantage insurance for seniors while operating a technology-driven model that improves healthcare quality and cost efficiency through a data and software platform that helps physicians with clinical decision-making, making it a health insurer with a tech-forward approach.
Over the past 1 year, roughly in the middle
18% below its 1-year high.
Traded about as much as usual. That is 97% of its average volume.
Next earnings report: November 4
5 days to go.
CLOV has a sound balance sheet but weak earning power
Of every $100 in sales, $0.74 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +51.7% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $98. Peers typically go for $502.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -38.9%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 27.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #9 of 11 in the industry
Based on market cap of $2B.
MOH#7 Molina Healthcare Inc $10B PER - 
OSCR#8 Oscar Health Inc $10B PER 22.5 CLOV#9 Clover Health Investments Corp $2B PER - 
PGNY#10 Progyny Inc $2B PER 30.9 
ALHC#11 Alignment Healthcare Inc $2B PER 43.2 
FAQ
What kind of company is CLOV?
CLOV belongs to the Healthcare sector and operates in the Healthcare Plans industry.
What is the market cap of CLOV?
The market cap of CLOV is approximately $2.4B, ranking 1,919 within its sector.
What is the 52-week high and low for CLOV?
CLOV has recorded a 52-week high of $5.59 and a low of $1.58.
